vs
ASPEN AEROGELS INC（ASPN）与RECURSION PHARMACEUTICALS, INC.（RXRX）财务数据对比。点击上方公司名可切换其他公司
ASPEN AEROGELS INC的季度营收约是RECURSION PHARMACEUTICALS, INC.的1.2倍（$41.3M vs $35.5M），ASPEN AEROGELS INC净利率更高（-176.4% vs -304.2%，领先127.9%），RECURSION PHARMACEUTICALS, INC.同比增速更快（681.7% vs -66.4%），ASPEN AEROGELS INC自由现金流更多（$13.7M vs $-47.3M），过去两年RECURSION PHARMACEUTICALS, INC.的营收复合增速更高（60.5% vs -33.9%）
Aspen Aerogels Inc是全球领先的气凝胶基高性能隔热及热管理材料生产商，产品广泛应用于可再生能源、油气基础设施、航空航天、商业建筑与工业制造领域，核心市场覆盖北美、欧洲及亚太地区，旗下材料以优异的耐热性、防火性能和轻量化特性广受客户认可。
Recursion Pharmaceuticals是一家临床阶段生物技术企业，依托人工智能技术和高通量生物实验体系，开发针对罕见病、肿瘤、炎症性疾病等领域未满足医疗需求的创新疗法，核心市场覆盖北美，与全球多家生物制药企业合作推进在研管线落地。
ASPN vs RXRX — 直观对比
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $41.3M | $35.5M |
| 净利润 | $-72.9M | $-108.1M |
| 毛利率 | -55.5% | 59.8% |
| 营业利润率 | -170.3% | -304.8% |
| 净利率 | -176.4% | -304.2% |
| 营收同比 | -66.4% | 681.7% |
| 净利润同比 | -741.7% | 39.6% |
| 每股收益（稀释后） | $-0.87 | $-0.17 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
| Q4 25 | $41.3M | $35.5M | ||
| Q3 25 | $73.0M | $5.2M | ||
| Q2 25 | $78.0M | $19.2M | ||
| Q1 25 | $78.7M | $14.7M | ||
| Q4 24 | $123.1M | $4.5M | ||
| Q3 24 | $117.3M | $26.1M | ||
| Q2 24 | $117.8M | $14.4M | ||
| Q1 24 | $94.5M | $13.8M |
| Q4 25 | $-72.9M | $-108.1M | ||
| Q3 25 | $-6.3M | $-162.3M | ||
| Q2 25 | $-9.1M | $-171.9M | ||
| Q1 25 | $-301.2M | $-202.5M | ||
| Q4 24 | $11.4M | $-178.9M | ||
| Q3 24 | $-13.0M | $-95.8M | ||
| Q2 24 | $16.8M | $-97.5M | ||
| Q1 24 | $-1.8M | $-91.4M |
| Q4 25 | -55.5% | 59.8% | ||
| Q3 25 | 28.5% | -183.8% | ||
| Q2 25 | 32.4% | -4.9% | ||
| Q1 25 | 29.0% | -48.0% | ||
| Q4 24 | 38.3% | -181.4% | ||
| Q3 24 | 41.8% | 53.7% | ||
| Q2 24 | 43.8% | 36.2% | ||
| Q1 24 | 37.2% | 19.1% |
| Q4 25 | -170.3% | -304.8% | ||
| Q3 25 | -4.6% | -3327.6% | ||
| Q2 25 | -6.6% | -916.8% | ||
| Q1 25 | -380.2% | -1297.9% | ||
| Q4 24 | 12.0% | -4042.4% | ||
| Q3 24 | 14.8% | -377.1% | ||
| Q2 24 | 17.0% | -697.4% | ||
| Q1 24 | 2.6% | -698.4% |
| Q4 25 | -176.4% | -304.2% | ||
| Q3 25 | -8.7% | -3135.3% | ||
| Q2 25 | -11.6% | -894.2% | ||
| Q1 25 | -382.7% | -1373.3% | ||
| Q4 24 | 9.2% | -3935.5% | ||
| Q3 24 | -11.1% | -367.5% | ||
| Q2 24 | 14.3% | -676.6% | ||
| Q1 24 | -1.9% | -662.4% |
| Q4 25 | $-0.87 | $-0.17 | ||
| Q3 25 | $-0.08 | $-0.36 | ||
| Q2 25 | $-0.11 | $-0.41 | ||
| Q1 25 | $-3.67 | $-0.50 | ||
| Q4 24 | $0.15 | $-0.56 | ||
| Q3 24 | $-0.17 | $-0.34 | ||
| Q2 24 | $0.21 | $-0.40 | ||
| Q1 24 | $-0.02 | $-0.39 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $156.9M | $743.3M |
| 总债务越低越好 | $65.5M | $9.6M |
| 股东权益账面价值 | $235.5M | $1.1B |
| 总资产 | $406.7M | $1.5B |
| 负债/权益比越低杠杆越低 | 0.28× | 0.01× |
8季度趋势，按日历期对齐
| Q4 25 | $156.9M | $743.3M | ||
| Q3 25 | $150.7M | $659.8M | ||
| Q2 25 | $167.6M | $525.1M | ||
| Q1 25 | $192.0M | $500.5M | ||
| Q4 24 | $220.9M | $594.4M | ||
| Q3 24 | $113.5M | $427.6M | ||
| Q2 24 | $91.4M | $474.3M | ||
| Q1 24 | $101.5M | $296.3M |
| Q4 25 | $65.5M | $9.6M | ||
| Q3 25 | $70.1M | $11.9M | ||
| Q2 25 | $77.3M | $14.2M | ||
| Q1 25 | $95.4M | $16.4M | ||
| Q4 24 | $95.0M | $19.0M | ||
| Q3 24 | $93.7M | $20.5M | ||
| Q2 24 | — | $22.9M | ||
| Q1 24 | — | — |
| Q4 25 | $235.5M | $1.1B | ||
| Q3 25 | $305.7M | $1.0B | ||
| Q2 25 | $308.8M | $919.1M | ||
| Q1 25 | $314.8M | $933.9M | ||
| Q4 24 | $614.7M | $1.0B | ||
| Q3 24 | $507.6M | $524.6M | ||
| Q2 24 | $517.8M | $584.4M | ||
| Q1 24 | $491.2M | $401.2M |
| Q4 25 | $406.7M | $1.5B | ||
| Q3 25 | $491.4M | $1.4B | ||
| Q2 25 | $525.1M | $1.3B | ||
| Q1 25 | $555.0M | $1.3B | ||
| Q4 24 | $895.1M | $1.4B | ||
| Q3 24 | $782.6M | $726.5M | ||
| Q2 24 | $748.6M | $775.9M | ||
| Q1 24 | $698.0M | $557.8M |
| Q4 25 | 0.28× | 0.01× | ||
| Q3 25 | 0.23× | 0.01× | ||
| Q2 25 | 0.25× | 0.02× | ||
| Q1 25 | 0.30× | 0.02× | ||
| Q4 24 | 0.15× | 0.02× | ||
| Q3 24 | 0.18× | 0.04× | ||
| Q2 24 | — | 0.04× | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $16.1M | $-46.1M |
| 自由现金流经营现金流 - 资本支出 | $13.7M | $-47.3M |
| 自由现金流率自由现金流/营收 | 33.1% | -133.1% |
| 资本支出强度资本支出/营收 | 6.0% | 3.5% |
| 现金转化率经营现金流/净利润 | — | — |
| 过去12个月自由现金流最近4个季度 | $-4.6M | $-378.3M |
8季度趋势，按日历期对齐
| Q4 25 | $16.1M | $-46.1M | ||
| Q3 25 | $15.0M | $-117.4M | ||
| Q2 25 | $-3.9M | $-76.4M | ||
| Q1 25 | $5.6M | $-132.0M | ||
| Q4 24 | $35.7M | $-115.4M | ||
| Q3 24 | $20.8M | $-59.2M | ||
| Q2 24 | $6.8M | $-82.2M | ||
| Q1 24 | $-17.7M | $-102.3M |
| Q4 25 | $13.7M | $-47.3M | ||
| Q3 25 | $5.9M | $-117.6M | ||
| Q2 25 | $-16.8M | $-79.6M | ||
| Q1 25 | $-7.4M | $-133.8M | ||
| Q4 24 | $20.9M | $-116.7M | ||
| Q3 24 | $-50.0K | $-63.8M | ||
| Q2 24 | $-18.0M | $-83.4M | ||
| Q1 24 | $-43.6M | $-109.0M |
| Q4 25 | 33.1% | -133.1% | ||
| Q3 25 | 8.1% | -2272.5% | ||
| Q2 25 | -21.6% | -413.9% | ||
| Q1 25 | -9.4% | -907.4% | ||
| Q4 24 | 17.0% | -2567.7% | ||
| Q3 24 | -0.0% | -244.6% | ||
| Q2 24 | -15.3% | -578.5% | ||
| Q1 24 | -46.1% | -789.9% |
| Q4 25 | 6.0% | 3.5% | ||
| Q3 25 | 12.5% | 4.7% | ||
| Q2 25 | 16.5% | 16.4% | ||
| Q1 25 | 16.5% | 12.4% | ||
| Q4 24 | 12.0% | 28.6% | ||
| Q3 24 | 17.7% | 17.5% | ||
| Q2 24 | 21.1% | 8.2% | ||
| Q1 24 | 27.4% | 48.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | 3.14× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | 0.41× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ASPN
| Energy Industrial | $14.5M | 35% |
| Other | $13.9M | 34% |
| Thermal Barrier | $12.9M | 31% |
RXRX
暂无分部数据
